1. Home
  2. MOLN vs AVD Comparison

MOLN vs AVD Comparison

Compare MOLN & AVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Molecular Partners AG

MOLN

Molecular Partners AG

HOLD

Current Price

$4.52

Market Cap

157.8M

Sector

N/A

ML Signal

HOLD

Logo American Vanguard Corporation ($0.10 Par Value)

AVD

American Vanguard Corporation ($0.10 Par Value)

HOLD

Current Price

$4.35

Market Cap

144.6M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
MOLN
AVD
Founded
2004
1969
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Agricultural Chemicals
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
157.8M
144.6M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
MOLN
AVD
Price
$4.52
$4.35
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
$4.00
$12.00
AVG Volume (30 Days)
6.4K
180.7K
Earning Date
10-30-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$530,073,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1,000.00
$3.54
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.36
$3.28
52 Week High
$5.99
$6.33

Technical Indicators

Market Signals
Indicator
MOLN
AVD
Relative Strength Index (RSI) 61.70 40.80
Support Level $3.99 $4.23
Resistance Level $4.61 $4.68
Average True Range (ATR) 0.16 0.20
MACD 0.02 -0.00
Stochastic Oscillator 84.92 21.74

Price Performance

Historical Comparison
MOLN
AVD

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

About AVD American Vanguard Corporation ($0.10 Par Value)

American Vanguard Corp is a United States-based diversified specialty and agricultural products company. It manufactures and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.

Share on Social Networks: